Gritstone bio, Inc.
NASDAQ:GRTS
0.0322 (USD) • At close October 21, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Revenue
| 1.331 | 9.269 | 46.717 | 4.037 | 4.365 | 1.187 | 0 | 0 |
Cost of Revenue
| 7.591 | 15.691 | 14.399 | 88.643 | 82.896 | 54.965 | 1.97 | 0.823 |
Gross Profit
| -6.26 | -6.422 | 32.318 | -84.606 | -78.531 | -53.778 | -1.97 | -0.823 |
Gross Profit Ratio
| -4.703 | -0.693 | 0.692 | -20.958 | -17.991 | -45.306 | 0 | 0 |
Reseach & Development Expenses
| 127.182 | 111.403 | 97.49 | 88.643 | 82.896 | 54.965 | 35.691 | 13.916 |
General & Administrative Expenses
| 28.783 | 28.97 | 25.933 | 21.411 | 19.409 | 11.806 | 6.072 | 5.064 |
Selling & Marketing Expenses
| -7.591 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 21.192 | 28.97 | 25.933 | 21.411 | 19.409 | 11.806 | 6.072 | 5.064 |
Other Expenses
| -0.032 | -10.676 | -1.497 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 148.374 | 129.697 | 121.926 | 110.054 | 102.305 | 66.771 | 41.763 | 18.98 |
Operating Income
| -154.634 | -120.428 | -75.209 | -106.017 | -97.94 | -65.584 | -41.763 | -18.98 |
Operating Income Ratio
| -116.179 | -12.993 | -1.61 | -26.261 | -22.438 | -55.252 | 0 | 0 |
Total Other Income Expenses Net
| 16.144 | 0.741 | 0.127 | 0.703 | 3.507 | 0.809 | 0.386 | 0.23 |
Income Before Tax
| -138.49 | -119.687 | -75.082 | -105.314 | -94.433 | -64.775 | -41.377 | -18.75 |
Income Before Tax Ratio
| -104.05 | -12.913 | -1.607 | -26.087 | -21.634 | -54.57 | 0 | 0 |
Income Tax Expense
| 7.423 | -6.56 | -0.127 | -0.703 | -3.507 | 0.809 | 0 | 0 |
Net Income
| -138.49 | -113.127 | -74.955 | -104.611 | -90.926 | -64.775 | -41.377 | -18.75 |
Net Income Ratio
| -104.05 | -12.205 | -1.604 | -25.913 | -20.831 | -54.57 | 0 | 0 |
EPS
| -1.2 | -1.24 | -0.95 | -2.77 | -2.71 | -7.26 | -2.06 | -0.93 |
EPS Diluted
| -1.2 | -1.24 | -0.95 | -2.77 | -2.71 | -7.26 | -2.06 | -0.93 |
EBITDA
| -147.043 | -118.452 | -68.862 | -99.373 | -93.195 | -61.623 | -39.793 | -18.157 |
EBITDA Ratio
| -110.476 | -12.779 | -1.474 | -24.616 | -21.351 | -51.915 | 0 | 0 |